| Total (n = 234) | Men (n = 131) | Women (n = 103) | P-value |
---|---|---|---|---|
Age (Year) | 53.4 ± 12.1 | 52 ± 11.9 | 55.2 ± 12.1 | 0.04 |
BMI (kg/m2) | 25.2 ± 3.8 | 25.5 ± 3.7 | 25.9 ± 3.9 | 0.22 |
SBP (mmHg) | 125.1 ± 15.5 | 126.7 ± 16.1 | 123.1 ± 14.4 | 0.07 |
DBP (mmHg) | 76.3 ± 9.7 | 77.3 ± 9.6 | 75 ± 9.7 | 0.07 |
HTN (%) | 134 (57.3%) | 72 (55%) | 62 (60%) | 0.25 |
DM duration (years) | 6.4 ± 6.2 | 6.1 ± 5.9 | 6.7 ± 6.7 | 0.46 |
HbA1C (%) | 8.3 ± 2.1 | 8.4 ± 2.2 | 8.1 ± 1.9 | 0.39 |
TC (mg/dl) | 170.6 ± 39.3 | 167.7 ± 39.6 | 174.2 ± 38.8 | 0.22 |
LDL-C (mg/dl) | 100.8 ± 35.5 | 99 ± 34.5 | 103.1 ± 36.7 | 0.40 |
HDL-C (mg/dl) | 47.5 ± 11.8 | 45.4 ± 11.3 | 50.1 ± 11.9 | 0.003 |
Triglyceride (mg/dl) | 119 (83, 179) | 128 (86,195) | 102 (82, 156) | 0.001 |
HsCRP (mg/dl) | 0.11 (0.06-0.24) | 0.1 (0.06, 0.24) | 0.12 (0.06, 0.23) | 0.50 |
HOMA-IR | 3.8 (2.4, 5.8) | 4.0 (2.4-6.1) | 3.6 (2.3-5.2) | 0.32 |
Mean ABI | 1.14 ± 0.08 | 1.14 ± 0.09 | 1.14 ± 0.06 | 0.89 |
Mean baPWV (cm/sec) | 1506 ± 313 | 1516 ± 320 | 1493 ± 304 | 0.59 |
Mean CIMT (mm) | 0.48 ± 0.14 | 0.48 ± 0.15 | 0.49 ± 0.14 | 0.89 |
VFT (mm) | 39 ± 16.1 | 41.9 ± 15.5 | 35.2 ± 16.2 | 0.002 |
SFT (mm) | 14.5 ± 5.8 | 13.8 ± 6 | 15.3 ± 5.5 | 0.039 |
VFT/SFT Ratio | 3.2 ± 2.1 | 3.5 ± 1.7 | 2.8 ± 2.4 | 0.01 |
ARB or ACEI, n(%) | 94 (40.2%) | 58 (44.3%) | 36 (35.3%) | 0.11 |
Statin, n (%) | 133 (57%) | 74 (56.5%) | 59 (57.8%) | 0.47 |
Antiplatelet agent, n (%) | 105 (45%) | 66 (50.4%) | 39 (38.2%) | 0.04 |
Thiazolidinediones, n (%) | 21 (9%) | 14 (10.7%) | 7 (6.8%) | 0.212 |
Smoking, n (%) | 48 (20.7%) | 43 (32.8%) | 5 (5%) | <0.001 |
Prevalence of CVD, n (%) | 27 (11.5%) | 18 (13.7%) | 7 (8.7%) | 0.304 |
Prevalence of DN, n (%) | 61 (26.1%) | 39 (30%) | 22 (21.4%) | 0.073 |